d-alpha tocopherol has been researched along with Hamartoma Syndrome, Multiple in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eng, C; Ni, Y | 1 |
1 other study(ies) available for d-alpha tocopherol and Hamartoma Syndrome, Multiple
| Article | Year |
|---|---|
Vitamin E protects against lipid peroxidation and rescues tumorigenic phenotypes in cowden/cowden-like patient-derived lymphoblast cells with germline SDHx variants.
Topics: alpha-Tocopherol; Antioxidants; Apoptosis; Cell Line, Transformed; Cell Transformation, Neoplastic; Germ-Line Mutation; Hamartoma Syndrome, Multiple; Humans; Lipid Peroxidation; Mitochondria; Oxidation-Reduction; Phenotype; Polymorphism, Genetic; Succinate Dehydrogenase; Tumor Suppressor Protein p53; Vitamin E | 2012 |